Literature DB >> 12144734

Adverse dermatologic effects of cardiovascular drug therapy: part I.

William H Frishman1, Brian D Brosnan, Marc Grossman, Debasish Dasgupta, And Diana K Sun.   

Abstract

Cardiovascular disease is common, affecting an increasing number of persons as the population ages. To combat this growing health problem, physicians use a multitude of medications in the treatment of their patients. Although pharmacologic therapy greatly enhances quality of life for a majority of patients, there is always the potential for an unfavorable reaction. For example, cardiovascular drugs can induce a vast array of adverse dermatologic responses. This article reviews the various cutaneous reaction patterns that can occur as a result of treatment with Class I and II antiarrhythmic agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144734     DOI: 10.1097/00045415-200207000-00008

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  2 in total

1.  Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma.

Authors:  K A Su; L A Habel; N S Achacoso; G D Friedman; M M Asgari
Journal:  Br J Dermatol       Date:  2018-08-14       Impact factor: 9.302

Review 2.  Alopecia in anticoagulated patients.

Authors:  Marcos Arêas Marques; Carmen Lucia Lascasas Porto; Ana Letícia de Matos Milhomens; Juliana de Miranda Vieira; Claudia Carvalho Alcântara Gomes; Ana Thereza Cavalcanti Rocha; Cíntia da Silva Miller
Journal:  J Vasc Bras       Date:  2020-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.